AI时代健康研究需同步伦理监督
Ethics oversight of health-related research should be contemporaneous in the age of artificial intelligence
《柳叶刀》文章揭示AI健康研究伦理监督滞后问题，研究团队缺乏伦理培训风险增加。
《柳叶刀》发表文章指出，AI在健康研究中的使用降低了研究门槛，导致研究团队可能缺乏伦理培训。研究到产品的生命周期缩短，使人群暴露于未被识别或纠正的不道德做法和安全风险中。
AI健康研究具有新特性，引入了新的伦理问题和风险。
Ethics oversight of health-related research should be contemporaneous in the age of artificial intelligence
The transformative impact of artificial intelligence (AI) on health-related research is widely recognised. However, AI-related health research has novel characteristics that introduce new ethical concerns and risks. The use of AI to carry out health-related research has lowered barriers to conducting such research, and research teams may lack credentials or training in research ethics. The research-to-product lifecycle can be of short duration, exposing populations to unethical practices and safety risks neither identified nor corrected during research or product development.
本条情报归属 AITOP「论文」核心栏目，重点聚焦欧洲人工智能治理与技术生态。在跨区域产业观察坐标中，该动态直接关联「各国 AI 监管法案、合规治理与主权算力政策」研究主线，反映出当前技术演进与商业落地的最新风向。涉及核心实体与技术议题包括：AI伦理、健康研究、伦理监督、研究伦理，读者可通过下方标签进入对应专题页查阅历史脉络与关联对比。
信源核验说明：本文原始线索采编自「Lancet Digital Health」（@Rohit Malpani, Keymanthri Moodley, Maria Magdalena Guraiib, Antonella Lavelanet, Andreas Reis），经 AITOP 多维评分管线结构化提炼。
